Iron in neurodegenerative disorders

Neurotoxicity Research

Volumn 4, Issue 7-8, 2002, Pages 637-653

  Berg, D ^a,b   Becker, G ^c   Riederer, P ^a,b   Riess O ^d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b National Parkinson Foundation   (United States)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Brain iron accumulation; Neurodegenerative disorders; Proteins of iron metabolism

Indexed keywords

IRON; RADICAL;

ADULT; DEGENERATIVE DISEASE; GENETIC ASSOCIATION; HUMAN; IRON METABOLISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; TISSUE SPECIFICITY;

EID: 0036853879     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1080/1029842021000045444     Document Type: Review

References (241)

1. Abboud, S. and Haile, D.J. (2000) "A novel mammalian iron-regulated protein involved in intracellular iron metabolism", J. Biol. Chem. 26, 19906-19912.
2. Adamec, J., Rusnak, F., Owen, W.G., Naylor, S., Benson, L.M., Gacy, A.M. and Isaya, G. (2000) "Iron dependent self-assembly of recombinant yeast frataxin. Implications for Friedreich Ataxia", Am. J. Hum. Genet. 67, 549-562.
3. Aisen, P., Wessling-Resnick, M. and Leibold, E.A. (1999) "Iron metabolism", Curr. Opin. Chem. Biol. 3, 200-206.
4. Aisen, P., Enns, C. and Wessling-Resnick, M. (2001) "Chemistry and biology of eukaryotic iron metabolism", Int. J. Biochem. Cell Biol. 33, 940-959.
5. Allikmets, R., Raskind, W.H., Hutchinson, A., Schueck, N.D., Dean, M. and Koeller, D.M. (1999) "Mutation of a putative mitochondrial iron tranpsorter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A)", Hum. Mol. Genet. 8, 743-749.
6. Arawaka, S., Saito, Y., Murayma, S. and Mori, H. (1998) "Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein", Neurology 51, 887-889.
7. Arima, K., Ueda, K., Sunohara, N., Arakawa, K., Hirai, S., Nakamura, M., Tonozuka-Uehara, H. and Kawai, M. (1998) "NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmatic inclusions in the pontine nuclei in multiple system atrophy", Acta Neuropathol. (Berl.) 96, 439-444.
8. Arosio, P., Levi, S., Santambrogio, P., Cozzi, A., Luzaggo, A., Cesareni, G. and Albertini, A. (1991) "Structural and functional studies of human ferritin H and L chains", In: Lenfant, A.A., Manucci, C.L. and Sixma, P.M., eds, Biotechnology of Plasma Proteins, (Karger, Basel), pp. 127-131.
9. Askwith, C. and Kaplan, J. (1998) "Iron and copper transport in yeast and its relevance to human disease", TIBS 23, 135-138.
10. Attieh, Z.K., Mukhopadhyay, C.K., Seshadri, V., Tripoulas, N.A. and Fox, P.L. (1999) "Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism", J. Biol. Chem. 274, 1116-1123.
11. Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M. and Kaplan, J. (1997) "Regulation of mitochondrial iron accumulation by Yfh1, a putative h Yfh1pmolg of frataxin", Science 276, 1709 -1712.
12. Bartzokis, G. and Tishler, T.A. (2000) "MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntington's disease", Cell Mol. Biol. 46, 821-833.
13. Bartzokis, G., Cummings, J., Perlman, S., Hance, D.B. and Mintz, J. (1999) "Increased basal ganglia iron levels in Huntington disease", Arch. Neurol. 56, 569-574.
14. Bartzokis, G., Sultzer, D., Cummings, J., Holt, L.E., Hance, D.B., Henderson, V.W. and Mintz, J. (2000) "In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging", Arch. Gen. Psychiatry 57, 47-53.
15. Beal M.F. (1998) "Mitochondrial dysfunction in neurodegenerative diseases", Biochim. Biophys. Acta 1366, 211-223.
16. Becker, E. and Des Richardson, R. (2001) "Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia", Int. J. Biochem. Cell Biol. 33, 1-10.
17. Becker, G., Seufert, J., Bogdahn, U., Reichmann, H. and Reiners, K. (1995) "Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography", Neurology 45, 182-184.
18. Bekri, S., Kispal, G., Lange, H., Fitzsimons, E., Tolmie, J., Lill, R. and Bishop, D.F. (2000) "Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation", Blood 96, 3256-3264.
19. Ben-Shachar, D., Riederer, P. and Youdim, M.B. (1991) "Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease", J. Neurochem. 57, 1609-1614.
20. Berg, D., Becker, G., Zeiler, B., Tucha, O., Hofmann, E., Preier, M., Benz, P., Jost, W., Reiners, K. and Lange, K.W. (1999) "Vulnerability of the nigrostriatal system as detected by transcranial ultrasound", Neurology 53, 1026-1031.
21. Berg, D., Hoggenmüller, U., Hoffmann, E., Fischer, R., Kraus, M., Scheurlen, M. and Becker, G. (2000) "The basal ganglia in haemochromatosis", Neuroradiology 42, 9-13.
22. Berg, D., Siefker, C. and Becker, G. (2001a) "Substantia nigra hyperechogenicity on transcranial ultrasound-state marker for Parkinson's disease and impact on disease course", J. Neurol. 248, 684-689.
23. Berg, D., Gerlach, M., Youdim, M.B.H., Doulbe, K.L., Zecca, L., Riederer, P. and Becker, G. (2001b) "Brain iron pathways and their relevance to Parkinson's disease", J. Neurochem. 79, 225-236.
24. Berg, D., Roggendorf, W., Schroder, U., Klein, R., Tatschner, T., Benz, P, Tucha, O., Preier, M., Lange, K.W., Reiners, K., Gerlach, M. and Becker, G. (2002) "Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury", Arch. Neurol. 59, 999-1005.
25. Boldt, D.H. (1999) "New perspectives on iron: an introduction", Am. J. Med. Sci. 318, 207-212.
26. Boll, M.-C., Sotelo, J., Otero, E., Alcaraz-Zubeldia, M. and Rios, C. (1999) "Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease", Neurosci. Lett. 265, 155-158.
27. Bonilla, E., Estevez, J., Suarez, H., Morales, L.M., de Bonilla, L.C., Villalobos, R. and Davila, J.O. (1991) "Serum ferritin in Huntington's disease patients", Neurosci. Lett. 129, 22-24.
28. Bost, M., Berkaw, M., McBride, O.W., Chazot, G. and Arnaud, P. (1995) "Restriction polymorphisms of the ceruloplasmin gene on chromosome 3", Hum. Genet. 96, 239-240.
29. Bradbury, M.W.B. (1997) "Transport of iron in the blood-brain-cerebrospinal fluid system", J. Neurochem. 69, 443-454.
30. Bradley, J.L., Blake, J.C., Chamberlain, S., Thomas, P.K., Cooper, J.M. and Schapira, A.H. (2000) "Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia", Hum. Mol. Genet. 9, 275-282.
31. Brown, R.H. and Robberecht, W. (2001) "Amyotrophic lateral sclerosis: pathogenesis", Semin. Neurol. 21, 131-139.
32. Bruyn, G.W. (1968) "Huntington's chorea: historical, clinical, and laboratory analysis", In: Vinken, P.J. and Bruyn, G.W., eds, Handbook of Clinical Neurology Vol. 6, pp. 379-396.
33. Burdo, J.R., Martin, J., Menzies, S.L., Dolan, K.G., Romano, M.A., Fletcher, R.J., Garrick, M.D., Garrick, L.M. and Connor, J.R. (1999) "Cellular distribution of iron in the brain of the Belgrade rat", Neuroscience 93, 1189-1196.
34. Bush, A.I. and Goldstein, L.E. (2001) "Specific metal-catalysed protein reactions in chronic degenerative disorders of ageing: focus on Alzheimer's disease and age-related cataracts", Novartis Found. Symp. 235, 26-43.
35. Cairo, G., Rappocciolo, E., Tacchini, L. and Schiaffonati, L. (1991) "Expression of genes for the ferritin H and L subunits in rat liver and heart", Biochem. J. 275, 813-816.
36. Campuzano, V., Montermini, L., Molto, M.D., Pianese, L., Cossee, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al., (1996) "Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion", Science 271, 1423-1427.
37. Campuzano, V., Montermini, L., Lutz, Y., et al., (1997) "Frataxin is reduced in Friedreich's ataxia patients and is associated with mitochondrial membranes", Hum. Mol. Genet. 61, 1771-1780.
38. Castellani, R.J., Smith, M.A., Nunomura, A., Harris, P.L. and Perry, G. (1999) "Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?" Free Radic. Biol. Med., 26, 1508-1512.
39. Chen, J.C., Hardy, P.A., Kucharczyk, W., Clauberg, M., Joshi, J.G., Vourlas, A., Dhar, M. and Henkelman, R.M. (1993) "MR and human postmortem brain tissue: correlation between T2 and assays of iron and ferritin in Parkinson and Huntington disease", AJNR 14, 275-281.
40. Chiueh, C.C. (2001) "Iron overload, oxidative stress, and axonal dystrophy in brain disorders", Pediatr. Neurol. 25, 138-147.
41. Cluskey, S. and Ramsden, D.B. (2001) "Mechanisms of neurodegeneration in amyotrophic lateral sclerosis", J. Clin. Pathol.: Mol. Pathol. 54, 386-392.
42. Coffey, C.E., Alston, S., Heinz, E.R. and Burger, P.C. (1989) "Brain iron in progressive supranuclear palsy: clinical, magnetic resonance imaging, and neuropathological findings", J. Neuropsychiatry Clin. Neurosci. 1, 400-404.
43. Connor, J. (1997) "Evidence for iron mismanagement in the brain in neurological disorders", In: Connor, J., ed, Metals and Oxidative Damage in Neurological Disorders (Plenum Press, New York), pp. 23-39.
44. Connor, J.R. and Benkovic, S.A. (1992) "Iron regulation in the brain: histochemical, biochemical, and molecular considerations", Ann. Neurol. 32, S51-S61.
45. Connor, J.R., Snyder, B.S., Beard, J.L., Fine, R.E. and Mufson, E.J. (1992) "The regional distribution of iron and iron regulatory proteins in the brain in aging and Alzheimer's disease", J. Neurosci. Res. 31, 327-335.
46. Cornett, C.R., Markesbery, W.R. and Ehmann, W.D. (1998) "Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain", Neurotoxicology 19, 339-345.
47. Cossee, M., Campuzano, V, Koutnikova, H., Fischbeck, K., Mandel, J.L., Koenig, M., Bidichandani, S.I., Patel, P.I., Molte, M.D., Canizares, J., De Frutos, R., Pianese, L., Cavalcanti, F., Monticelli, A., Cocozza, S., Montermini, L. and Pandolfo, M. (1997) "Frataxin fracas", Nat. Genet. 15, 337-338.
48. Cossee, M., Durr, A., Schmitt, M., Dahl, N., Trouillas, P., Allinson, P., Kostrzewa, M., Nivelon-Chevallier, A., Gustavson, K.H., Kohlschutter, A., Muller, U., Mandel, J.L., Brice, A., Koenig, M., Cavalcanti, F., Tammaro, A., De Michele, G., Filla, A., Cocozza, S., Labuda, M., Montermini, L., Poirier, J. and Pandolfo, M. (1999) "Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes", Ann. Neurol. 45, 200-206.
49. Csere, P., Lill, R. and Kispal, G. (1998) "Identification of a human mitochondrial ABC transporter, the functional orthologue of yeast Atm1p", FEBS Lett. 441, 266-270.
50. Curtis, A.R.J., Fey, C., Morris, C.M., Bindoff, L.A., Ince, P.G., Chinnery, P.F., Coulthard, A., Jackson, M.J., Jackson, A.P., McHale, D.P., Hay, D., Barker, W.A., Markham, A.F., Bates, D., Curtis, A. and Burn, J. (2001) "Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease", Nat. Genet. 28, 350-354.
51. Daimon, M., Yamatani, K., Igarashi, M., Fukase, N., Kawanami, T., Kato, T., Tominaga, M. and Sasaki, H. (1995a) "Fine structure of the human ceruloplasmin gene", Biochem. Biophys. Res. Commun. 208, 1028-1035.
52. Daimon, M., Morita, Y., Yamatani, K., Igarashi, M., Fukase, N., Kawanami, T., Kato, T., Tominaga, M. and Sasaki, H. (1995b) "Dinucleotide repeat polymorphism in the human ceruloplasmin gene", Hum. Genet. 96, 736.
53. De Castro, M., Garcia-Planells, J., Monros, E., Canizares, J., Vazquez-Manrique, R., Vilchez, J.J., Urtasun, M., Lucas, M., Navarro, G., Izquierdo, G., Molto, M.D. and Palau, F. (2000) "Genotype and phenotype analysis of Friedreich's ataxia compound heterozygous patients", Hum. Genet. 106, 86-92.
54. Dean, M. and Allikmets, R. (1995) "Evolution of ATP-binding cassette transporter genes", Curr. Opin. Genet. Dev. 5, 779-785.
55. Deibel, M.A., Ehmann, W.D. and Markesbery, W.R. (1996) "Copper, iron, and zinc imbalances in severely degenerated bran regions in Alzheimer's disease: possible relation to oxidative stress", J. Neurol. Sci. 143, 137-142.
56. Demarquay, G., Setiey, A., Morel, Y., Trepo, C., Chazot, G. and Broussolle, E. (2000) "Clinical report of three patients with hereditary hemochromatosis and movement disorders", Mov. Disord. 15, 1204-1209.
57. Dexter, D.T., Wells, F.R., Lees, A.J., Agid, F., Agid, Y., Jenner, P. and Marsden, C.D. (1989) "Increased nigral iron content and alterations in other metal ions occuring in brain in Parkinson's disease", J. Neurochem. 52, 1830-1836.
58. Dexter, D.T., Jenner, P., Schapira, A.H.V. and Marsden, C.D. (1992) "Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia", Ann. Neurol. 32, 94-100.
59. Dickson, D.W., Wen-Lang, L., Wan-Kyun, L. and Shu-Hui, Y. (1999) "Multiple system atrophy: a sporadic synucleinopathy", Brain Pathol. 9, 721-732.
60. Donovan, A., Brownlie, A., Zhou, Y., et al., (2000) "Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter", Nature 403, 776-781.
61. Dooling, E.C., Schoene, W.C. and Richardson, Jr., E.P. (1974) "Hallervorden-Spatz syndrome", Arch. Neurol. 1974, 70-83.
62. Double, K.L., Maywald, M., Schmittel, M., Riederer, P. and Gerlach, M. (1998) "In vitro studies of ferritin iron release and neurotoxicity", J. Neurochem. 70, 2492-2499.
63. Double, K.L., Riederer, P. and Gerlach, M. (1999) "Significance of neuromelanin for neurodegeneration in Parkinson's disease", Drug News Perspect. 12, 333-340.
64. Drysdale, J.W. (1988) "Human ferritin gene expression", Prog. Nucleic Acids Res. Mol. Biol. 35, 127-155.
65. Durr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.L., Brice, A. and Koenig, M. (1996) "Clinical and genetic abnormalities in Friedreich's ataxia", N. Engl. J. Med. 335, 1169-1175.
66. Emond, M., Lepage, G., Vanasse, M. and Pandolfo, M. (2000) "Increased levels of plasma malondialdehyde in Friedreich ataxia", Neurology 55, 1752-1753.
67. Faucheux, B.A., Nillesse, N., Damier, P., Spik, G., Mouatt-Prigent, A., Pierce, A., Leveugle, B., Kubis, N., Hauw, J.J., Agid, Y., et al., (1995) "Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson's disease", Proc. Natl Acad. Sci. USA 92, 9603-9607.
68. Fernandez Leite, J. (2001) "Huntington's disease: a bimolecular vision", Rev. Neurol. 32, 762-767.
69. Fillebeen, C., Mitchell, V., Dexter, D., Benaissa, M., Beauvillain, J.C., Spik, G. and Pierce, A. (1999) "Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment", Mol. Brain. Res. 72, 183-194.
70. Foury, F. (1999) "Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain", FEBS Lett. 456, 281-284.
71. Foury, F. and Talibi, D. (2000) "Mitochondrial control of iron homeostasis: a genome wide analysis of gene expression in a yeast frataxin deficient mutant", J. Biol. Chem. 276, 7762-7768.
72. Gai, W.P., Power, J.H., Blumbergs, P.C. and Blessing, W.W. (1998) "Multiple-system atrophy: a new alpha-synuclein disease", Lancet 352, 547-648.
73. Galvin, J.E., Giasson, B., Hurtig, H.I., Lee, V.M. and Trojanowski, J.Q. (2000) "Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology", Am. J. Pathol. 157, 361-368.
74. Gattermann, N., Aul, C. and Schneider, W. (1993) "Is acquired idiopathic sideroblastic anemia (AISA) a disorder of mitochondrial DNA?", Leukemia 7, 2069-2076.
75. Gaudette, M., Hirano, M. and Siddique, T. (2000) "Current status of SOD1 mutations in amyotrophic lateral sclerosis", Amyotrophic Lateral Sclerosis and Other Motoneuron Diseases 1, 83-90.
76. Gerlach, M., Ben-Shachar, D., Riederer, P. and Youdim, M.B. (1994) "Altered brain metabolism of iron as a cause of neurodegenerative diseases", J. Neurochem. 63, 793-807.
77. Gerlach, M., Reichmann, H. and Riederer, P. (2001) Die Parkinsonkrankheit, Grundlagen, Klinik, Therapie (Springer, Wien, NY).
78. Girelli, D., Corrocher, R., Bisceglia, L., Olivieri, O., Zelante, L., Panozzo, G. and Gaspari, P. (1997) "Hereditary hyperferritinemia-cataract syndrome caused by a 29-base pair deletion in the iron responsive element of ferritin L-subunit gene", Blood 90, 2084-2088.
79. Gitlin, J.D. (1998) "Aceruloplaminemia", Pediatr. Res. 44, 271-276.
80. Golts, N., Snyder, H., Frasier, M., Theisler, C., Choi, P. and Wolozin, B. (2002) "Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein", J. Biol. Chem. 277, 16116-16123.
81. Gordon, N. (2000) "Friedreich's ataxia and iron metabolism", Brain Dev. 22, 465-468.
82. Gorell, J.M., Ordidge, R.J., Brown, G.G., Deniau, J.C., Buderer, N.M. and Helpern, J.A. (1995) "Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease", Neurology 45, 1138-1143.
83. Götz, M., Künig, K., Riederer, P. and Youdim, M. (1994) "Oxidative stress: free radical production in neural degeneration", Pharmacol. Ther. 63, 37-122.
84. Griffiths, P.D., Dobson, B.R., Jones, G.R. and Clarke, D.T. (1999) "Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption find structure and cryoelectron microscopy", Brain 122, 667-673.
85. Gruenheid, S., Canonne-Hergaux, F., Gauthier, S., Hackam, D.J., Grinstein, S. and Gros, P. (1999) "The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes", J. Exp. Med. 189, 831-841.
86. Gunshin, H., Mackenzie, B., Berger, U.V, Gunshin, Y., Romero, M.F., Boron, W.F., Nussberger, S., Gollan, J.L. and Hediger, M.A. (1997) "Cloning and characterisation of mammalian proton-coupled metal-ion transporter", Nature 388, 482-488.
87. Gutierrez, J.A., Yu, J., Rivera, S. and Wessling-Resnick, M. (1997) "Functional expression cloning and characterization of SFT, a stimulator of Fe transport", J. Cell Biol. 139, 895-905.
88. Gutierrez, J.A., Yu, J. and Wessling-Resnick, M. (1998) "Characterization and chromosomal mapping of the human gene for SFT, a stimulator of Fe transport", Biochem. Biophys. Res. Commun. 253, 739-742.
89. Haile, D.J. (1999) "Regulation of genes of iron metabolism by the iron-response proteins", Am. J. Med. Sci. 318, 230-240.
90. Hallgren, B. and Sourander, P. (1958) "The effect of age on non-haem iron in the human brain", J. Neurochem. 3, 41-51.
91. Halliday, W. (1995) "The nosology of Hallervorden-Spatz disease", J. Neurol. Sci. 134, 84-91.
92. Halliwell, B. (2001) "Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment", Drugs Aging 18, 685-716.
93. Harding, A.E. (1981) "Friedreich's ataxia: a clinical a genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features", Brain 104, 598-620.
94. Harris, Z.L., Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, R.T. and Giltin, J.D. (1995) "Aceruloplasminemia: molecular characterization of this disorder of iron metabolism", Proc. Natl Acad. Sci. USA 92, 2539-2543.
95. Harris, Z.L., Durley, A.P., Man, T.K. and Giltin, J.D. (1999) "Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux", Proc. Natl Acad. Sci. USA 96, 10812-10817.
96. Harrison, P.M. and Arrosio, P. (1996) "The ferritin: molecular properties, iron storage function and cellular regulation", Biochim. Biophys. Acta 1275, 161-203.
97. Hashimoto, M., Hsu, L.J., Sisk, A., Xia, Y., Takeda, A., Sundsmo, M. and Masliah, E. (1998) "Human recombinant NACP/alphasynuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease", Brain Res. 799, 301-306.
98. Hashimoto, M., Hsu, L.J., Xia, Y., Takeda, A., Sisk, A. and Masliah, E. (1999) "Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro", NeuroReport 10, 717-721.
99. Hellier, K.D., Hatchwell, E., Duncombe, A.S., Kew, J. and Hammans, S.R. (2001) "X-linked sideroblastic anemia with ataxia: another mitochondrial disease?", J. Neurol. Neurosurg. Psychiatry 70, 65-69.
100. Hellmann, N.E., Kono, S., Miyajima, H. and Gitlin, J.D. (2002) "Biochemical analysis of a missense mutation in aceruloplasminemia", J. Biol. Chem. 277, 1375-1380.
101. Hentze, M.W. and Kuhn, L.C. (1996) "Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress", Proc. Natl Acad. Sci. USA 93, 8175-8182.
102. Hickman, S.J., Ward, N.S., Surtees, R.A.H., Stevens, J.M. and Farmer, S.F. (2001) "How broad is the phenotype of Hallervorden-Spatz disease", Acta Neurol. Scand. 103, 201-203.
103. Higgins, C.F. (1992) "ABC transporters: from microorganisms to man", Annu. Rev. Cell. Biol. 8, 67-113.
104. Hilditch-Maguire, P., Trettel, F., Passani, L.A., Auerbach, A., Persichetti, F. and MacDonald, M.E. (2000) "Huntingtin: a iron regulated protein essential for normal nuclear and perinuclear organelles", Hum. Mol. Genet. 9, 2789-2797.
105. Huntington's Disease Collaborative Research Group(1993) "A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes", Cell 72, 971-983.
106. Imon, Y., Yamaguchi, S., Yamamura, Y., Tsuji, S., Kajima, T., Ito, K. and Nakamura, S. (1995) "Low intensity areas observed on T2-weighted magnetic resonance imaging of the cerebral cortex in various neurological disorders", J. Neurol. Sci. 134 (Suppl.), 27-32.
107. Jefferies, W.A., Food, M.R., Gabathuler, R., Rothenberger, S., Yamada, T., Yasuhara, O. and McGeer, P.L. (1996) "Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin", Brain Res. 712, 122-126.
108. Jellinger, K., Riederer, P. and Tomonaga, M. (1980) "Progressive supranuclear palys: clinicopathological and biochemical studies", J. Neural Transm. Suppl. 16, 111-128.
109. Jellinger, K., Kienzl, E., Rumpelmaier, G., Riederer, P., Stachelberg, H., Ben-Shachar, D. and Youdim, M.B. (1992) "Iron-melanin complex in substantia nigra of Parkinsonian brains: an X-ray microanalysis", J. Neurochem. 59, 1168-1171.
110. Jellinger, K.A. (1999) "The role of iron in neurodegeneration", Drugs Aging 14, 115-140.
111. Jones, A.L. (1996) "The Huntington's disease gene and its protein product", In: Harper, P.S., ed, Huntington's Disease, 2nd Ed. (W.B. Saunders Co., Philadelphia), pp. 293-316.
112. Karthikeyan, G., Lewis, L.K. and Resnick, M.A. (2002) "The mitochondrial protein frataxin prevents nuclear damage", Hum. Mol. Genet. 16, 1351-1362.
113. Kasarski, E.J., Tandon, L., Lovell, M.A. and Ehmann, W.D. (1995) "Aluminium, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study", J. Neurol. Sci. 130, 203-208.
114. Kato, S., Nakamura, H., Hirano, A., Ito, H., Llena, J.F. and Yen, S.H. (1991) "Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy)", Acta Neuropathol. (Berl.) 82, 488-493.
115. Kato, J., Fujikawa, K., Kanda, M., Fukuda, N., Sasaki, K., Takayama, T., Kobune, M., Takada, K., Takimoto, R., Hamada, H., Ikeda, T. and Niitsu, Y. (2001) "A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload", Am. J. Hum. Genet. 69, 191-197.
116. Kennard, M.L., Feldman, H., Yamada, T. and Jefferies, W.A. (1996) "Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease", Nat. Med. 2, 1230-1235.
117. Kim, D.K., Seo, M.Y., Lim, S.W., Kim, S., Kim, J.W., Carroll, B.J., Kwon, D.Y., Kwon, T. and Kang, S.S. (2001) "Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease", Neuropsychopharmacology 25, 84-90.
118. Kispal, G., Csere, P., Guiard, B. and Lill, R. (1997) "The ABC transporter Atm1p is required for mitochondrial iron homeostasis", FEBS Lett. 418, 346-350.
119. Kispal, G., Csere, P., Prohl, C. and Lill, R. (1999) "The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins", EMBO J. 18, 3981-3989.
120. Klomb, L.W. and Gitlin, J.D. (1996) "Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenetic model in aceruloplasminea", Hum. Mol. Gen. 5, 1989-1996.
121. Knutson, M.D., Levy, J.E., Andrews, N.C. and Wessling-Resnick, M. (2001) "Expression of stimulator of Fe transport is not enhanced in Hfe knockout mice", J. Nutr. 131, 1459-1464.
122. Koeppen, A.H. and Dickson, A.C. (2001) "Iron in Hallervorden-Spatz syndrome", Pediatr. Neurol. 25, 148-155.
123. Kohno, S., Miyajima, H. and Takahashi, Y. (1999) "Aceruloplasminemia with a novel mutation associated with parkinsonism", Neurogenetics 2, 237-238.
124. Kohno, S., Miyajima, H., Takahashi, Y., Suzuki, H. and Hishida, A. (2000) "Defective electron transfer in complex I and IV in patients with aceruloplasminemia", J. Neurol. Sci. 182, 57-60.
125. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. (1998) "Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease", Nat. Genet. 18, 106-108.
126. Lamarche, J.B., Cote, M. and Lemieux, B. (1980) "The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases", Can. J. Neurol. Sci. 7, 389-396.
127. Lasker, A.G., Zee, D.S., Hain, T.C., Folstein, S.E. and Singer, H.S. (1987) "Saccades in Huntingon's disease: initiation defects and distractability", Neurology 37, 364.
128. Leveugle, B., Spik, G., Perl, D.P, Bouras, C., Fillit, H.M. and Hof, P.R. (1994) "The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis", Brain Res. 650, 20-31.
129. Leveugle, B., Faucheux, B.A., Bouras, C., Nillesse, N., Spik, G., Hirsch, E.C., Agid, Y. and Hof, P.R. (1996) "Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease", Acta Neuropathol. 91, 566-572.
130. LeVine, S.M. (1997) "Iron deposits in multiple sclerosis and Alzheimer's disease brains", Brain Res. 760, 298-303.
131. Levy, J.E., Jin, O., Fujiwara, Y., Kuo, F. and Andrews, N.C. (1999) "Transferrin receptor is necessary for development of erythorcytes and the nervous system", Nat. Genet. 21, 396-399.
132. Lodi, R., Hart, P.E., Rajagopalan, B., Taylor, D.J., Crilley, J.G., Bradley, J.L., Blamire, A.M., Manners, D., Styles, P., Schapira, A.H. and Cooper, J.M. (2001a) "Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia", Ann. Neurol. 49, 590-596.
133. Lodi, R., Taylor, D.J. and Schapira, A.H.V (2001b) "Mitochondrial dysfunction in Friedreich's ataxia", Biol. Signals Recept. 10, 263-270.
134. Loeffler, D.A., Le Witt, P.A., Juneau, P.L., Sima, A.A., Nguyen, H.U., DeMaggio, A.J., Brickman, C.M., Brewer, G.J., Dick, R.D., Troyer, M.D. and Kanaley, L. (1996) "Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders", Brain. Res. 738, 265-274.
135. Loeffler, D.A., Sima, A.A. and LeWitt, P.A. (2001) "Ceruloplasmin immunoreactivity in neurodegenerative disorders", Free Radic. Res. 35, 111-118.
136. Lopiano, L., Chiesa, M., Digilio, G., Giraudo, S., Bergamasco, B., Torre, E. and Fasano, M. (2000) "Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients", Biochim. Biophys. Acta 1500, 306-312.
137. Loreal, O., Turlin, B., Pigeon, C., Moisan, A., Ropert, M., Morice, P., Gandon, Y., Jouanolle, A.M., Verin, M., Hider, R.C., Yoshida, K. and Brissot, P. (2002) "Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights", J. Hepatol. 36, 851-856.
138. Lutz, T., Westermann, B., Neupert, W. and Herrmann, J.M. (2001) "The mitochondrial proteins Ssq1 and Jac1 are required for the assembly of iron sulfur clusters in mitochondria", J. Mol. Biol. 307, 815-825.
139. Lynch, D.R., Farmer, J.M., Balcer, L.J. and Wilson, R.B. (2002) "Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy", Arch. Neurol. 59, 743-747.
140. Malecki, E.A., Devenyi, A.G., Beard, J.L. and Connor, J.R. (1999) "Existing and emerging mechanisms for transport of iron and manganese to the brain", J. Neurosci. Res. 56, 113-122.
141. Mandel, S., Grunblatt, E. and Youdim, M. (2000) "cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease", J. Neural Transm. Suppl. 60, 117-124.
142. Martin, J.B. and Gusella, J.F. (1986) "Huntington's diease: pathogenesis and management", N. Engl. J. Med. 315, 1267-1276.
143. Martin, M.E., Fargion, S., Brissot, P., Pellat, B. and Beaumont, C. (1998a) "A point mutation in the bulge of the iron-responsive element of the L ferritin gene in two families with the hereditary hyperferritinemia-cataract syndrome", Blood 91, 319-323.
144. Martin, W.R., Roberts, T.E., Ye, F.Q. and Allen, P.S. (1998) "Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance", Can. J. Neurol. Sci. 25, 44-47.
145. McKie, A., T,., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T.J., Farzaneh, F., Hediger, M.A., Hentze, M.W. and Simpson, R.J. (2000) "A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation", Mol. Cell 5, 299-309.
146. Medrum, B. and Garthwaite, J. (1990) "Excitatory amino acid neurotoxicity and neurodegenerative disease", Trends Pharmacol. Sci., 54-62, A TiPS special report.
147. Miyajima, H., Kohno, S., Takahashi, Y., Yonekawa, O. and Kanno, T. (1999) "Estimation of the gene frequency of aceruloplasminemia in Japan", Neurology 53, 617-619.
148. Miyajima, H., Kohno, S., Takahashi, Y., Sugimoto, M., Sakamoto, M. and Skai, N. (2001) "Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation", Neurology 26, 2205-2210.
149. Mohanakumar, K.P., de Bartolomeis, A., Wu, R.M., Yeh, K.J., Sternberger, L.M., Peng, S.Y., Murphy, D.L. and Chiueh, C.C. (1994) "Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid peroxidation", Ann. N.Y. Acad. Sci. 738, 392-399.
150. Moos, T. and Morgan, E.H. (1998) "Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid", J. Neurosci. Res. 54, 468-494.
151. Moos, T. and Morgan, E.H. (2000) "Transferrin and transferrin receptor function in brain barrier systems", Cell Mol. Neurobiol. 20, 77-95.
152. Morita, H., Ikeda, S., Yamamoto, K., Morita, S., Yoshida, K., Nomoto, S., Kato, M. and Yanagisawa, N. (1995) "Hereditary ceruloplasmin deficiency with hemosiderosis: a clinico-pathological study of a Japanese familiy", Ann. Neurol. 37, 646-656.
153. Muhlenhoff, U. and Lill, R. (2000) "Biogenesis of iron-sulfur proteins in eukaryotes: a novel task of mitochondria that is inherited from bacteria", Biochim. Biophys. Acta 1459, 370-382.
154. Mukhopadhyay, C.K., Attieh, Z.K. and Fox, P.L. (1998) "Role of ceruloplasmin in cellular iron uptake", Science 279, 714-717.
155. Neumann, M., Adler, S., Schlüter, O., Kremmer, E., Benecke, R. and Kretzschmar, H.A. (2000) "2α-Synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBlA-1, formerly Hallervorden-Spatz syndrome). with widespread cortical and brainstem-type Lewy bodies", Acta Neuropathol. 100, 568-574.
156. Nielsen, J.E., Neerup Jensen, L. and Krabbe, B. (1995) "Heredita haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome", J. Neurol. Neurosurg. Psychiatry 59, 318-578.
157. Oba, H., Araki, T., Ohtomo, K., Monzawa, S., Uchiyama, G., Koizumi, K., Nogata, Y., Kachi, K., Shiozawa, Z. and Kobayashi, M. (1993) "Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging", Radiology 189, 843-846.
158. Obata, T. (2002) "Role of hydroxyl radical formation in neurotoxicity as revealed by in vivo free radical trapping", Toxicol. Lett. 132, 83-93.
159. Oeda, T., Shimohama, S., Kitagawa, N., Kohno, R., Imura, T.,
160. Okamato, N., Wada, S., Oga, T., Kawabata, Y., Baba, Y., Habu, D., Takeda, Z. and Wada, Y. (1996) "Hereditary ceruloplasmin deficiency with hemosiderosis", Hum. Genet. 97, 755-758.
161. Olanow, C.W. (1992) "Magnetic resonance imaging in parkinsonism", Neurol. Clin. 10, 405-420.
162. Olney, J.W., Ho, O.L. and Rhee, V. (1971) "Cytotoxic effect of acidic and sulfur containing amino acids on the infant mouse central nervous system", Exp. Brain Res. 14, 61-76.
163. Olsen, M.K., Roberds, S.L., Ellerbrock, B.R., Fleck, T.J., McKinley, D.K. and Gurney, M.E. (2001) "Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord", Ann. Neurol. 50, 730-740.
164. Oskai, S., Johnson, D.A. and Frieden, E. (1966) "The possible role of the ferrous oxidase activity of ceruloplasmin in normal human serum", J. Biol. Chem. 241, 11490-11491.
165. Ostergaard, J.R., Christensen, T. and Hansen, K.N. (1995) "In vivo diagnosis of Hallervorden-Spatz disease", Dev. Med. Child. Neurol. 37, 827-833.
166. Osterova-Golts, N., Petrucelli, L., Hardy, J., Lee, J.M., Farer, M. and Wolozin, B. (2000) "The A53T α-synuclein mutation increases iron dependent aggregation and toxicity", J. Neurosci. 20, 6048-6054.
167. Pagon, R.A., Bird, T.D., Detter, J.C. and Pierce, I. (1985) "Hereditary sideroblastic anaemia and ataxia: an X-linked recessive disorder", J. Med. Genet. 22, 267-273.
168. Paik, S., Shin, H., Lee, J., Chang, C. and Kim, J. (1999) "Copper(II)-induced self oligomerization of α-synuclein", Biochem. J. 340, 821-828.
169. Park, L.C., Albers, D.S., Xu, H., Lindsay, J.G., Beal, M.F. and Gibson, G.E. (2001) "Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy", J. Neurosci. Res. 66, 1028-1034.
170. Patel, I.P. and Isaya, G. (2001) "Freidreich ataxia: from GAA triplet-repeat expansion to frataxin deficiency", Am. J. Hum. Genet. 69, 15-24.
171. Patel, B.N., Dunn, R.J. and David, S. (2000) "Alternative RNA splicing generates a glycosylphosphtidylinositol-anchored form of ceruloplasmin in mammalian brain", J. Biol. Chem. 275, 4305-4310.
172. Paxinos, G., ed, (1990) The Human Nervous System (Academic Press, San Diego, CA).
173. Perez, M., Valpuesta, J.M., Montejo de Garcini, E. and Avila, J. (1998) "Ferritin is associated with the aberrant tau filaments in preogressive supranuclear palsy", Am. J. Pathol. 152, 1531-1539.
174. Perry, T.L., Norman, M.G., Yong, V.W, Whiting, S., Crichton, J.U., Hansen, S. and Kish, S.J. (1985) "Hallervorden-Spatz disease: cystein accumulation and cystein dioxygenase deficiency in the globus pallidus", Ann. Neurol. 18, 482-489.
175. Piemonte, F., Pastore, A., Tozzi, G., Tagliacozzi, D., Santorelli, F.M., Carrozzo, R., Casali, C., Damiano, M., Federici, G. and Bertini, E. (2001) "Glutathione in blood of patients with Friedreich's ataxia", Eur. J. Clin. Investig. 31, 1007-1011.
176. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., Di Iorio, G., Golbe, L.I. and Nussbaum, R.L. (1997) "Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease", Science 276, 2045-2047.
177. Ponka, P. (1999) "Cellular iron metabolism", Kidney Int. 55 (Suppl. 69), 2-11.
178. Pook, M.A., Al Mahdawi, S.A., Thomas, N.H., Appleton, R., Norman, A., Mountford, R. and Chamberlain, S. (2000) "Identification of three novel frameshift mutations in patients with Friedreich's ataxia", J. Med. Genet. 37, E38.
179. Powell, H.C., London, G.W. and Lampert, P.W. (1974) "Neurofibrillary tangles in progressive supranuclear palsy: electron microscopic observations", J. Neuropathol. Exp. Neurol. 33, 98-106.
180. Qian, Z.M. and Ke, Y. (2001) "Rethinking the role of ceruloplasmin in brain iron metabolism", Brain Res. Rev. 35, 287-294.
181. Qian, Z.M. and Shen, X. (2001) "Brain iron transport and neurodegeneration", Trends Mol. Med. 7, 103-108.
182. Qian, Z.M. and Wang, Q. (1998) "Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders", Brain Res. Rev. 27, 257-267.
183. Racette, B.A., Perry, A., D'Avossa, G. and Perlmutter, J.S. (2001) "Late-onset neurodegeneration with brain iron accumulation type 1: expanding the clinical spectrum", Mov. Disord. 16, 1148-1152.
184. Radisky, D.C., Bacock, M.C. and Kaplan, J. (1999) "The yeast frataxin homologue mediates mitochondrial iron efflux: evidence for a mitochondrial iron cycle", J. Biol. Chem. 274, 4497-4499.
185. Raskind, W.H., Wijsman, E., Pagon, R.A., Cox, T.C., Bawden, M.J., May, B.K. and Bird, T.D. (1991) "X-linked sideroblastic anemia and ataxia: linkage to phosphoglycerate kinase a Xq13", Am. J. Hum. Genet. 48, 335-341.
186. Reilly, C.A. and Aust, S.D. (1997) "Stimulation of the ferroxidase activity of ceruloplasmin during the iron loading into ferritin", Arch. Biochem. Biophys. 347, 242-248.
187. Riederer, P., Sofic, E., Rausch, W.D., Kruzik, P. and Youdim, M.B.H. (1985) "Dopaminforschung heute und morgen-L-Dopa in der Zukunft", In: Riederer, P. and Umek, H., eds, L-Dopa-Substitution der Parkinsonkrankheit, Geschichte-Gegenwart-Zukunft (Springer, Wien, NY), pp. 127-144.
188. Riederer, P., Sofic, E., Rausch, W.D., Schmidt, B., Reynolds, G.P., Jeellinger, K. and Youdim, M.B.H. (1989) "Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains", J. Neurochem. 52, 515-520.
189. Riederer, P., Dirr, A., Goetz, M., Sofic, E., Jellinger, K. and Youdim, M.B. (1992) "Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease", Ann. Neurol. 32, 101-104.
190. Rock, C.O., Calder, R.B., Karim, M.A. and Jackowski, S. (2000) "Pantothenate kinase regulation of the intracellular concentration of coenzym A", J. Biol. Chem. 14, 1377-1383.
191. Rosen, R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H.X., et al., (1993) "Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis", Nature 362, 59-62.
192. Rotig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A. and Rustin, P. (1997) "Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia", Nat. Genet. 17, 215-217.
193. Rouault, T. (2001) "Systemic iron metabolism: a review and implications for brain iron metabolism", Pediatr. Neurol. 25, 130-137.
194. Rustin, P., VonKleist-Retzow, J.C., Chantrel-Goussard, K., Sidi, D., Munnich, A. and Rotig, A. (1999) "Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study", Lancet 354, 477-479.
195. Rutledge, J.N., Hilal, S.K., Silver, A.J., Defendini, R. and Fahn, S. (1987) "Study of movement disorders and brain iron by MR", AJNR 8, 397-411.
196. Ryvlin, P., Broussolle, E., Piollet, H., Viallet, F., Khalfallah, Y. and Chazot, G. (1995) "Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease", Arch. Neurol. 52, 583-588.
197. Sampieto, M., Caputo, L., Casatta, A., Meregalli, M., Pellagatti, A., Tagliabue, J., Annoni, G. and Vergani, C. (2001) "The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease", Neurobiol. Aging 22, 563-568.
198. Savoiardo, M., Halliday, W.C., Nardocci, N., Strada, L., D'Incerti, L., Angelini, L., Rumi, V. and Tesoro-Tess, J.D. (1993) "Hallervorden-Spatz disease. MR and pathologic findings", Am. J. Neuroradiol. 14, 155-162.
199. Savoreido, M., Girotti, F., Strada, L. and Ciceri, E. (1994) "Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders", J. Neural Transm. Suppl. 42, 93-110.
200. Sayre, L.M., Zelasko, D.A., Harris, P.L.R., Perry, G., Salomon, R.G. and Smith, M.A. (1997) "4-Hydroxynonenal-derived advanced lipid peroxidation end products increased in Alzheimer's disease", J. Neurochem. 68, 2092-2097.
201. Sayre, L.M., Perry, G. and Smith, M.A. (1999) "Redox metals and neurodegenerative diseases", Curr. Opin. Chem. Biol. 3, 220-225.
202. Sayre, L.M., Perry, G., Harris, P.L., Liu, Y., Schubert, K.A. and Smith, M.A. (2000) "In situ oxidative calalysis by neurofibrillary tangles and senile palques in Alzheimer's disease: a central role for bound transition metals", J. Neurochem. 74, 270-279.
203. Schipper, H.M. (2000) "Heme oxygenase-1: role in brain aging and neurodegeneration", Exp. Gerontol. 35, 821-830.
204. Senbongi, H., Ling, F. and Shibata, T. (1999) "A mutation in a mitochondrial ABC transporter results in mitochondrial dysfunction through oxidative damage of mitochondrial DNA", Mol. Gen. Genet. 262, 426-436.
205. Sheth, S. and Briitenham, G.M. (2000) "Geneticdisorders affecting proteins of iron metabolism: clinical implications", Ann. Rev. Med. 51, 443-464.
206. Shimada, Y., Okuno, S., Kawai, A., Shinomiya, H., Saito, A., Suzuki, M., Omori, Y., Nishino, N., Kanemoto, N., Fujiwara, T., Horie, M. and Takahashi, E. (1998) "Cloning an chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia", J. Hum. Genet. 43, 115-122.
207. Shoham, S. and Youdim, M.B. (2000) "Iron involvement in neural damage and microgliosis in models of neurodegerative disorders", Cell Mol. Biol. 46, 743-760.
208. Smith, M.A., Harris, P.L.R., Sayre, L.M., Beckmann, J.S. and Perry, G. (1997) "Widespread peroxynitrite-mediated damage in Alzheimer's disease", J. Neurosci. 17, 2653-2657.
209. Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G.P., Hebenstreit, G. and Youdim, M.B. (1988) "Increased iron (III). and total iron content in post mortem substantia nigra of parkinsonian brain", J. Neural. Transm. 74, 199-205.
210. Spillantini, M.G., Crowther, R.A., Jakes, R., Cairns, N.J., Lantos, P.L. and Goedert, M. (1998) "Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies", Neurosci. Lett. 251, 205-208.
211. Swaiman, K.F. (1991) "Hallervorden-Spatz syndrome and brain iron metabolism", Arch. Neurol. 48, 1285-1293.
212. Swaiman, K.F. (2001) "Hallervorden-Spatz syndrome", Pediatr. Neurol. 25, 102-108.
213. 59 Fe-studies in Hallervorden-Spatz syndrome", Neurology 33, 301-305.
214. Tabucchi, M., Yoshimori, T., Yamaguchi, K., Yoshida, T. and Kishi, F. (2000) "Human NRAMP2/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in Hep-2 cells", J. Biol. Chem. 21, 22220-22228.
215. Taylor, T.D., Litt, M., Kramer, P., Pandolfo, M., Angelini, L., Nardocci, N., Davis, S., Pineda, M., Hattori, H., Flett, P.J., Cilio, M.R., Bertini, E. and Hayflick, S.J. (1996) "Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13", Nat. Genet. 14, 479-481.
216. Telenius, H., Kremer, H.P.H., Theilmann, J., Andrew, S.E., Almqvist, E., Anvret, M., Greenberg, C., Greenberg, J., Lucotte, G., Squitieri, F., et al., (1993) "Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent", Hum. Mol. Genet. 4, 1535-1540.
217. Theil, E.C. (1987) "Ferritin; structure, gene regulation, and cellular function in animals, plants and microorganisms", Annu. Rev. Biochem. 56, 289-315.
218. Theil, E.C. (2000) "Targeting mRNA to regulate iron and oxygen metabolism", Biochem. Pharmacol. 59, 87-93.
219. Troncoso, J.C., Costello, A., Watson, A.L. Jr. and Johnson, G.V. (1993) "In vitro polymerization of oxidized tau into filaments", Brain Res. 613, 313-316.
220. Vulpe, C.D., Kuo, Y.M., Murphy, L., Cowley, L., Askwith, C., Libina, N., Gitschier, J. and Anderson, G.J. (1999) "Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse", Nat. Genet. 21, 195-199.
221. Vymazal, J., Righini, A., Brooks, R.A., Canesi, M., Mariani, C., Leonardi, M. and Pezzoli, G. (1999) "T1 and T2 in the brain of healthy subjects, patients with Pakinson disease and patients with multiple system atrophy: relation to iron content", Radiology 211, 489-495.
222. Waldvogel, D., van Gelderen, M. and Hallett, M. (1999) "Increased iron content in the dentate nucleus of patients with Friedreich's ataxia", Ann. Neurol. 46, 123-135.
223. Whetsell, W.O. (1996) "Current concept of excitotoxicity", J. Neuropathol. Exp. Neurol. 55, 1-13.
224. Wilson, R.B., Lynch, D.R. and Fischbeck, K.H. (1998) "Normal serum iron and ferritin concentrations in patients with Friedreich's ataxia", Ann. Neurol. 44, 132-134.
225. Wilson, R.B., Lynch, D.R., Farmer, J.M., Brooks, D.G. and Fischbeck, K.H. (2000) "Increased serum transferrin receptor concentrations in Friedreich ataxia", Ann. Neurol. 47, 659-661.
226. Witte, D., Crosby, W., Edwards, C., Fairbanks, V. and Mitros, F. (1996) "Hereditary hemochromatosis", Clin. Chim. Acta 245, 139-200.
227. Yamada, T., Tsujioka, Y., Taguchi, J., Takahashi, M., Tsuboi, Y., Moroo, I., Yang, J. and Jefferies, W.A. (1999) "Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease", Brain Res. 845, 1-5.
228. Yang, F., Naylor, S.L., Lum, J.B., Cutshaw, S., McCombs, J.L., Naberhaus, K.H., McGill, J.R., Adrian, G.S., Moore, C.M., Barnett, D.R. and Bowman, B.H. (1986) "Characterization, mapping, and expression of the human ceruloplasmin gene", Proc. Natl Acad. Sci. USA 83, 3257-3261.
229. Yasui, M., Ota, K. and Garruto, R.M. (1993) "Concentration of zinc and iron in the brains of Guamanian patients with amytrophic lateral sclerosis and parkinsonism-demetia", Neurotoxicology 14, 445-450.
230. Yoon, S.J., Koh, Y.H., Floyd, R.A. and Park, J.W. (2000) "Copper, zinc superoxide dismutase enhances DNA damage and mutagenicity induced by cystein/iron", Mutat. Res. 448, 97-104.
231. Yoshida, T., Tanaka, M., Sotomatsu, A. and Hirai, S. (1995) "Activated microglia cause superoxide-mediated release of iron from ferritin", Neurosci. Lett. 190, 21-24.
232. Yoshida, K., Kaneko, K., Miyajima, H., Tokuda, T., Nakamura, A., Kato, M. and Ikeda, S.-I. (2000) "Increased lipid peroxidation in the brains of aceruloplasminemia patients", J. Neurol. Sci. 175, 91-95.
233. Youdim, M., Ben-Shachar, D. and Riederer, P. (1991) "Iron in brain function and dysfunction with emphasis on Parkinson's disease", Eur. Neurol. 31, 34-40.
234. Youdim, M.B. and Riederer, P. (1997) "Understanding Parkinson's disease", Sci. Am. 276, 52-59.
235. Young, S.P., Fahmy, M. and Golding, S. (1997) "Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells", FEBS Lett. 411, 93-96.
236. Zecca, L., Shima, T., Stroppolo, A., Goj, C., Battistron, G.A., Gerbasi, R., Sarna, T. and Swartz, H.M. (1996) "Interaction of neuromelanin and iron in the substantia nigra and other areas of human brain", Neuroscience 73, 407-415.
237. Zecca, L., Gallorini, M., Schünemann, V., Trautwein, A.X., Gerlach, M., Riederer, P., Vezzoni, P. and Tampellini, D. (2001) "Iron, neuromelanin and ferritin in substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes", J. Neurochem. 76, 1766-1773.
238. Zecca, L., Costi, P., Mecacci, C., Ito, S., Terreni, M. and Sonnino, S. (2000) "Interaction of human substantia nigra neuromelanin with lipids and peptides", J. Neurochem. 74, 1758-1765.
239. Zecca, L., Fariello, R., Riederer, P., Sulzer, D., Gatti, A. and Tampellini, D. (2002) "The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease", FEBS Lett. 510, 216-220.
240. Zhou, B., Westaway, S.K., Levinson, B., Johnson, M.A., Gitschier, J. and Hayflick, S.J. (2001) "A novel pantothenate kinase gene (PANK2). is defective in Hallervorden-Spatz syndrome", Nat. Genet. 28, 345-349.
241. Zupanc, M.L., Chun, R.W.M. and Gilbert-Barness, E.F. (1990) "Osmiophilic deposits in cytosomes in Hallervorden-Spatz syndrome", Pediatr. Neurol. 6, 345-352.